{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:09:16Z","timestamp":1789009756216,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lanzhou Youth Science and Technology Talent Innovation Project","award":["(2024-QN-165)"],"award-info":[{"award-number":["(2024-QN-165)"]}]},{"name":"Gansu Province Technology Innovation Guidance Program - East-West Collaboration Special Project","award":["(23CXNA0016)"],"award-info":[{"award-number":["(23CXNA0016)"]}]},{"name":"Gansu Provincial Joint Scientific Research Fund - Major Project","award":["(25JRRA1086)"],"award-info":[{"award-number":["(25JRRA1086)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-026-05702-6","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:14:47Z","timestamp":1785136487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isolation of feline-derived scFvs against the VP1-CDE region of feline calicivirus from a phage display library and characterization of their antigen-binding and antiviral potential in vitro"],"prefix":"10.1186","volume":"22","author":[{"given":"Yanquan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huitian","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"67","key":"5702_CR1","first-page":"382","volume":"18","author":"LB Fastier","year":"1957","unstructured":"Fastier LB. A new feline virus isolated in tissue culture. Am J Vet Res. 1957;18(67):382\u20139.","journal-title":"Am J Vet Res"},{"issue":"3","key":"5702_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1023\/A:1015253621079","volume":"26","author":"Y Sato","year":"2002","unstructured":"Sato Y, Ohe K, Murakami M, Fukuyama M, Furuhata K, Kishikawa S, Suzuki Y, Kiuchi A, Hara M, Ishikawa Y, et al. Phylogenetic analysis of field isolates of feline calcivirus (FCV) in Japan by sequencing part of its capsid gene. Vet Res Commun. 2002;26(3):205\u201319.","journal-title":"Vet Res Commun"},{"issue":"Pt 2","key":"5702_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1099\/vir.0.82488-0","volume":"88","author":"RJ Ossiboff","year":"2007","unstructured":"Ossiboff RJ, Sheh A, Shotton J, Pesavento PA, Parker JSL. Feline caliciviruses (FCVs) isolated from cats with virulent systemic disease possess in vitro phenotypes distinct from those of other FCV isolates. J Gen Virol. 2007;88(Pt 2):506\u201317.","journal-title":"J Gen Virol"},{"key":"5702_CR4","doi-asserted-by":"crossref","unstructured":"Wang D, Zhu J, Yang H, Lyu Y. Epidemiology and Molecular Characterization of Feline Calicivirus in Beijing, China. Animals. 2025;15(4).","DOI":"10.3390\/ani15040494"},{"key":"5702_CR5","doi-asserted-by":"publisher","first-page":"101023","DOI":"10.1016\/j.tcam.2025.101023","volume":"69","author":"M Slaviero","year":"2025","unstructured":"Slaviero M, de Almeida BA, de Castro LT, Panziera W, Pavarini SP, Driemeier D, Sonne L. Feline herpesvirus and calicivirus: Occurrence and pathology in cats with respiratory disease. Top companion Anim Med. 2025;69:101023.","journal-title":"Top companion Anim Med"},{"key":"5702_CR6","doi-asserted-by":"publisher","first-page":"1636514","DOI":"10.3389\/fimmu.2025.1636514","volume":"16","author":"A Tang","year":"2025","unstructured":"Tang A, Li B, Zhu M, Zhu S, Zhang D, Li N, Zhang M, Zhu Y, Li C, Meng C, et al. A novel feline herpesvirus vector subunit FCV VP1 and FPV VP2 vaccine protects cats against FHV-1 and FPV challenge and induces serum neutralizing antibody responses against FCV. Front Immunol. 2025;16:1636514.","journal-title":"Front Immunol"},{"key":"5702_CR7","doi-asserted-by":"publisher","first-page":"1388420","DOI":"10.3389\/fmicb.2024.1388420","volume":"15","author":"Y Wei","year":"2024","unstructured":"Wei Y, Zeng Q, Gou H, Bao S. Update on feline calicivirus: viral evolution, pathogenesis, epidemiology, prevention and control. Front Microbiol. 2024;15:1388420.","journal-title":"Front Microbiol"},{"issue":"1","key":"5702_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12917-024-03914-2","volume":"20","author":"L Li","year":"2024","unstructured":"Li L, Liu Z, Shi J, Yang M, Yan Y, Fu Y, Shen Z, Peng G. The CDE region of feline Calicivirus VP1 protein is a potential candidate subunit vaccine. BMC Vet Res. 2024;20(1):80.","journal-title":"BMC Vet Res"},{"key":"5702_CR9","doi-asserted-by":"crossref","unstructured":"Yang Y, Qi R, Chen M, Feng K, Liu Z, Kang H, Jiang Q, Qu L, Liu J. Screening and Immune Efficacy Evaluation of Antigens with Protection Against Feline Calicivirus. Vaccines. 2024;12(11).","DOI":"10.3390\/vaccines12111205"},{"key":"5702_CR10","doi-asserted-by":"publisher","first-page":"106272","DOI":"10.1016\/j.antiviral.2025.106272","volume":"243","author":"Y Yang","year":"2025","unstructured":"Yang Y, Song H, Zhang K, Wang S, Zhao Y, Zhang Q, Jin M. Efficient eukaryotic expression and potent antiviral activity of a long-acting recombinant feline interferon-omega2-Fc fusion protein against major feline viruses. Antiviral Res. 2025;243:106272.","journal-title":"Antiviral Res"},{"key":"5702_CR11","doi-asserted-by":"crossref","unstructured":"Lee G, Budhathoki S, Lee GY, Oh KJ, Ham YK, Kim YJ, Lim YR, Hoang PT, Lee Y, Lim SW et al. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro. Viruses. 2021;13(4).","DOI":"10.3390\/v13040650"},{"key":"5702_CR12","doi-asserted-by":"crossref","unstructured":"van Dorsten RT, Lambson BE, Wibmer CK, Weinberg MS, Moore PL, Morris L. Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope. J Virol. 2020;94(2).","DOI":"10.1128\/JVI.01533-19"},{"key":"5702_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.antiviral.2018.12.019","volume":"162","author":"C Li","year":"2019","unstructured":"Li C, Wang Y, Liu T, Niklasch M, Qiao K, Durand S, Chen L, Liang M, Baumert TF, Tong S, et al. An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion. Antiviral Res. 2019;162:118\u201329.","journal-title":"Antiviral Res"},{"issue":"45","key":"5702_CR14","doi-asserted-by":"publisher","first-page":"18523","DOI":"10.1073\/pnas.1215549109","volume":"109","author":"HB Larman","year":"2012","unstructured":"Larman HB, Xu GJ, Pavlova NN, Elledge SJ. Construction of a rationally designed antibody platform for sequencing-assisted selection. Proc Natl Acad Sci USA. 2012;109(45):18523\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5702_CR15","doi-asserted-by":"publisher","first-page":"e17143","DOI":"10.7717\/peerj.17143","volume":"12","author":"X Zheng","year":"2024","unstructured":"Zheng X, Liu Q, Liang Y, Feng W, Yu H, Tong C, Song B. Advancement in the development of single chain antibodies using phage display technology. PeerJ. 2024;12:e17143.","journal-title":"PeerJ"},{"issue":"8","key":"5702_CR16","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.drudis.2022.05.002","volume":"27","author":"L Ledsgaard","year":"2022","unstructured":"Ledsgaard L, Ljungars A, Rimbault C, Sorensen CV, Tulika T, Wade J, Wouters Y, McCafferty J, Laustsen AH. Advances in antibody phage display technology. Drug Discovery Today. 2022;27(8):2151\u201369.","journal-title":"Drug Discovery Today"},{"key":"5702_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-3381-6_1","volume":"2702","author":"A Nur","year":"2023","unstructured":"Nur A, Schubert M, Lai JY, Hust M, Choong YS, Isa W, Lim TS. Antibody Phage Display. Methods Mol Biol. 2023;2702:3\u201312.","journal-title":"Methods Mol Biol"},{"key":"5702_CR18","doi-asserted-by":"publisher","first-page":"117880","DOI":"10.1016\/j.bios.2025.117880","volume":"289","author":"M Liu","year":"2025","unstructured":"Liu M, Xi L, Wang Z, Wang Y, Gao X, Wei H, Feng Y, Wang J, Wu Q, Shang Y, et al. Recent advances in M13 phage display: Novel strategies of construction and biopanning recognition elements for food safety detection. Biosens Bioelectron. 2025;289:117880.","journal-title":"Biosens Bioelectron"},{"key":"5702_CR19","doi-asserted-by":"crossref","unstructured":"Mendoza-Salazar I, Gomez-Castellano KM, Gonzalez-Gonzalez E, Gamboa-Suasnavart R, Rodriguez-Luna SD, Santiago-Casas G, Cortes-Paniagua MI, Perez-Tapia SM, Almagro JC. Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library. Antibodies. 2022;11(1).","DOI":"10.3390\/antib11010013"},{"issue":"2","key":"5702_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0166-0934(97)00099-2","volume":"67","author":"BH Muller","year":"1997","unstructured":"Muller BH, Lafay F, Demangel C, Perrin P, Tordo N, Flamand A, Lafaye P, Guesdon JL. Phage-displayed and soluble mouse scFv fragments neutralize rabies virus. J Virol Methods. 1997;67(2):221\u201333.","journal-title":"J Virol Methods"},{"issue":"9","key":"5702_CR21","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1016\/j.jia.2023.07.039","volume":"22","author":"JX Song","year":"2023","unstructured":"Song JX, Wang MX, Zhang YX, Wan B, Du YK, Zhuang GQ, Li ZB, Qiao SL, Geng R, Wu YN, et al. Identification and epitope mapping of anti-p72 single-chain antibody against African swine fever virus based on phage display antibody library. J Integr Agr. 2023;22(9):2834\u201347.","journal-title":"J Integr Agr"},{"issue":"1","key":"5702_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2249.2001.01515.x","volume":"125","author":"K Ray","year":"2001","unstructured":"Ray K, Embleton MJ, Jailkhani BL, Bhan MK, Kumar R. Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1. Clin Exp Immunol. 2001;125(1):94\u2013101.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"5702_CR23","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/eji.200526134","volume":"35","author":"RA Kramer","year":"2005","unstructured":"Kramer RA, Marissen WE, Goudsmit J, Visser TJ, Clijsters-Van der Horst M, Bakker AQ, de Jong M, Jongeneelen M, Thijsse S, Backus HH, et al. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol. 2005;35(7):2131\u201345.","journal-title":"Eur J Immunol"},{"key":"5702_CR24","doi-asserted-by":"crossref","unstructured":"Kim JW, Cho AH, Shin HG, Jang SH, Cho SY, Lee YR, Lee S. Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants. Viruses. 2023;15(1).","DOI":"10.3390\/v15010174"},{"issue":"1","key":"5702_CR25","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.1038\/s41598-017-12725-5","volume":"7","author":"Z Lu","year":"2017","unstructured":"Lu Z, Tallmadge RL, Callaway HM, Felippe MJB, Parker JSL. Sequence analysis of feline immunoglobulin mRNAs and the development of a felinized monoclonal antibody specific to feline panleukopenia virus. Sci Rep. 2017;7(1):12713.","journal-title":"Sci Rep"},{"issue":"1","key":"5702_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13567-020-00785-x","volume":"51","author":"C Cubillos-Zapata","year":"2020","unstructured":"Cubillos-Zapata C, Angulo I, Almanza H, Borrego B, Zamora-Ceballos M, Caston JR, Mena I, Blanco E, Barcena J. Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and nonneutralizing monoclonal antibodies. Vet Res. 2020;51(1):59.","journal-title":"Vet Res"},{"issue":"8","key":"5702_CR27","doi-asserted-by":"publisher","first-page":"e0009325","DOI":"10.1128\/jvi.00093-25","volume":"99","author":"W Heng","year":"2025","unstructured":"Heng W, Zang D, Li R, Jiang Q, Liu J, Jia H, Kang H. A novel replication-deficient FCV vaccine provides strong immune protection in cats. J Virol. 2025;99(8):e0009325.","journal-title":"J Virol"},{"key":"5702_CR28","doi-asserted-by":"crossref","unstructured":"Fumian TM, Tuipulotu DE, Netzler NE, Lun JH, Russo AG, Yan GJH, White PA. Potential Therapeutic Agents for Feline Calicivirus Infection. Viruses. 2018;10(8).","DOI":"10.3390\/v10080433"},{"issue":"3\u20134","key":"5702_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.vetimm.2014.01.012","volume":"158","author":"CJ Strietzel","year":"2014","unstructured":"Strietzel CJ, Bergeron LM, Oliphant T, Mutchler VT, Choromanski LJ, Bainbridge G. In vitro functional characterization of feline IgGs. Vet Immunol Immunopathol. 2014;158(3\u20134):214\u201323.","journal-title":"Vet Immunol Immunopathol"},{"key":"5702_CR30","doi-asserted-by":"crossref","unstructured":"Berinstein NL, Pennell NM, Weerasinghe R, Buckstein R, Piliotis E, Imrie KR, Chodirker L, Cussen MA, Miles E, Reis MD et al. Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with (90) Y ibritumomab tiuxetan in a phase II study. Hematological oncology. 2018.","DOI":"10.1002\/hon.2513"},{"issue":"5","key":"5702_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4161\/mabs.2.5.12720","volume":"2","author":"F Li","year":"2010","unstructured":"Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A. Cell culture processes for monoclonal antibody production. Mabs-Austin. 2010;2(5):466\u201379.","journal-title":"Mabs-Austin"},{"issue":"30","key":"5702_CR32","doi-asserted-by":"publisher","first-page":"27688","DOI":"10.1021\/acsomega.3c03581","volume":"8","author":"N Rasri","year":"2023","unstructured":"Rasri N, Tabtimmai L, Kraiya C, Yamabhai M, Sinthuvanich C, Rattanasrisomporn J, Choowongkomon K. Generation of a Single-Chain Variable Fragment Antibody against Feline Immunoglobulin G for Biosensor Applications. ACS omega. 2023;8(30):27688\u201396.","journal-title":"ACS omega"},{"issue":"1","key":"5702_CR33","first-page":"401","volume":"57","author":"SS LI Meng","year":"2026","unstructured":"LI Meng SS, Zipan LI, Yuntiao XU, Zibei HUANG, Jianya LUO, Yiheng ZHAO, Xin GUO, Hongkai BIAN, Xinyu PAN, Wenbo LIU. Preparation and Application of Cat PD-L1 Monoclonal Antibody and Feline Derived Single Chain Antibody. Acta Vet et Zootechnica Sinica. 2026;57(1):401\u201313.","journal-title":"Acta Vet et Zootechnica Sinica"},{"issue":"2","key":"5702_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1292\/jvms.60.155","volume":"60","author":"T Tajima","year":"1998","unstructured":"Tajima T, Yoshizaki S, Nakata E, Tohya Y, Ishiguro S, Fujikawa Y, Sugii S. Production of a monoclonal antibody reacted broadly with feline calicivirus field isolates. J Vet Med Sci. 1998;60(2):155\u201360.","journal-title":"J Vet Med Sci"},{"issue":"1","key":"5702_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0378-1119(98)00593-9","volume":"227","author":"DG Zahra","year":"1999","unstructured":"Zahra DG, Vancov T, Dunn JM, Hawkins NJ, Ward RL. Selectable in vivo recombination to increase antibody library size\u2013an improved phage display vector system. Gene. 1999;227(1):49\u201354.","journal-title":"Gene"},{"key":"5702_CR36","volume-title":"Phage display: a laboratory manual. Cold Spring Harbor","author":"CF Barbas","year":"2001","unstructured":"Barbas CF. Phage display: a laboratory manual. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory Press; 2001."},{"issue":"Pt 2","key":"5702_CR37","doi-asserted-by":"publisher","first-page":"128645","DOI":"10.1016\/j.ijbiomac.2023.128645","volume":"257","author":"Y Li","year":"2024","unstructured":"Li Y, Song J, Jiang S, Yang Y, Han Y, Zhong L, Zhou J, Wang M, Song H, Xu Y. Canine distemper virus (CDV)-neutralizing activities of an anti-CDV canine-derived single-chain variable antibody fragment 4\u201315 (scFv 4\u201315) screened by phage display technology. Int J Biol Macromol. 2024;257(Pt 2):128645.","journal-title":"Int J Biol Macromol"},{"key":"5702_CR38","doi-asserted-by":"publisher","first-page":"110837","DOI":"10.1016\/j.vetmic.2025.110837","volume":"312","author":"Y Sun","year":"2026","unstructured":"Sun Y, Li T, Liu J, Guo D, Xu L, Hu B, Zeng H, Cao W, Deng X, Ji Z, et al. A recombinant Fc-fused nanobody provides complete protection against feline parvovirus infection. Vet Microbiol. 2026;312:110837.","journal-title":"Vet Microbiol"},{"issue":"6","key":"5702_CR39","first-page":"531","volume":"158","author":"L Xia","year":"2015","unstructured":"Xia L, Zhang J, Cui C, Bi X, Xiong J, Yu H, An Z, Luo W, Xia N. In vitro affinity maturation and characterization of anti-P24 antibody for HIV diagnostic assay. J BioChem. 2015;158(6):531\u20138.","journal-title":"J BioChem"},{"key":"5702_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2018.11.001","volume":"161","author":"B Zhou","year":"2019","unstructured":"Zhou B, Xu L, Zhu R, Tang J, Wu Y, Su R, Yin Z, Liu D, Jiang Y, Wen C, et al. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential. Antiviral Res. 2019;161:28\u201335.","journal-title":"Antiviral Res"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-026-05702-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05702-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05702-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:59:41Z","timestamp":1789009181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12917-026-05702-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5702"],"URL":"https:\/\/doi.org\/10.1186\/s12917-026-05702-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8778333\/v1","asserted-by":"object"}]},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Two adult male cats, owned by Lanzhou Aibokang Pet Hospital, were housed at the Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences. Informed consent was obtained from the owners for their use in this study. These two types of cats were used for both antigen inoculation and peripheral blood lymphocyte isolation in this study. The experiments and protocols for this study were approved by Gansu Agricultural University (Approval No. VMC2025007) and the Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, China (Approval No. 2025\u201372).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"529"}}